Hemophilia A and B global drug market size in 2016 and 2026

This statistic shows the hemophilia A and B drug market size in leading markets worldwide in 2016 and a forecast for 2026. In 2016, the drug market size for hemophilia A and B was around 6.7 billion U.S. dollars and was expected to grow to some 8 billion dollars by 2026.

Hemophilia A and B drug market size in leading markets worldwide in 2016 and 2026 (in billion U.S. dollars)*

Loading statistic...
You need to log in to download this statistic
Register for free
Already a member?
Log in
Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

July 2017

Region

Worldwide

Survey time period

2016

Supplementary notes

* Leading countries include the US, France, Germany, Italy, Spain, the UK and Japan.
** Forecast

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Bleeding disorders in the U.S."

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.